TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21352597

Group type: EXPERIMENTAL
Intervention: 3-year school-based lifestyle improvement program
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Health-promoter agents (university students) implementing nutritional and physical activity objectives
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group following usual activities
Number of subjects: 38
Study: 19755646

Group type: EXPERIMENTAL
Intervention: $5 cash with the initial mailing
Number of subjects: 6359

Group type: EXPERIMENTAL
Intervention: $20 promise upon completion of the information form (for cases)
Number of subjects: 6359

Group type: EXPERIMENTAL
Intervention: $10 promise upon completion of the baseline survey (for relatives)
Number of subjects: 6359

Group type: COMPARATOR
Intervention: Registered mail
Number of subjects: 6359

Group type: COMPARATOR
Intervention: First-class mail
Number of subjects: 6359
Study: 16420574

Group type: EXPERIMENTAL
Intervention: 2 ng kg(‐1) National Reference Endotoxin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 20
Study: 15018698

Group type: EXPERIMENTAL
Intervention: Standard education
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Further education (randomized group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Baseline assessment
Number of subjects: 40
Study: 11397724

Group type: EXPERIMENTAL
Intervention: 450 mL of black tea initially, followed by 900 mL daily for 4 weeks
Number of subjects: 49

Group type: COMPARATOR
Intervention: Water consumed initially, followed by 900 mL daily for 4 weeks
Number of subjects: 49
Study: 9415352

Group type: EXPERIMENTAL
Intervention: Immediate asthma education
Number of subjects: 125

Group type: COMPARATOR
Intervention: Delayed asthma education (Control)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Age over 60 years
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Age categories
Number of subjects: 125
Study: 8424519

Group type: EXPERIMENTAL
Intervention: OTFC (7‐10 micrograms/kg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo identical in appearance to OTFC
Number of subjects: 38
Study: 3631182

Group type: EXPERIMENTAL
Intervention: Intracameral carbachol
Number of subjects: 44

Group type: COMPARATOR
Intervention: Balanced salt solution (Control)
Number of subjects: 44
Study: 30034230

Group type: EXPERIMENTAL
Intervention: TIO+OLO 5/5 μg
Number of subjects: 461

Group type: COMPARATOR
Intervention: TIO 5 μg
Number of subjects: 461
Study: 27173787

Group type: EXPERIMENTAL
Intervention: PR/simeprevir (triple) therapy
Number of subjects: 300

Group type: COMPARATOR
Intervention: PR therapy
Number of subjects: 300
Study: 24836914

Group type: EXPERIMENTAL
Intervention: Reading and language intervention (two 9-week blocks of daily intervention delivered by trained teaching assistants)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Typical classroom instruction (9 weeks) followed by intervention (9 weeks)
Number of subjects: 145
Study: 22504121

Group type: EXPERIMENTAL
Intervention: Imagery rescripting of early memories
Number of subjects: 14

Group type: COMPARATOR
Intervention: Reading task
Number of subjects: 14
Study: 20368068

Group type: EXPERIMENTAL
Intervention: Lian propofol TCI system (6 microg/ml initial target plasma concentration)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Marsh system (control group)
Number of subjects: 90
Study: 18060419

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) without alendronate
Number of subjects: 48

Group type: COMPARATOR
Intervention: Extracorporeal shockwave therapy (ESWT) with alendronate
Number of subjects: 48
Study: 15807187

Group type: EXPERIMENTAL
Intervention: Pulse therapy (2 microg oral Alfacalcidol twice or thrice weekly)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Daily therapy (0.5 microg oral Alfacalcidol per day)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Pulse therapy
Number of subjects: 158

Group type: COMPARATOR
Intervention: Daily therapy
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 158
Study: 12211526

Group type: EXPERIMENTAL
Intervention: Autologous hematopoietic stem cell transplantation (HSCT) following high-dose chemotherapy
Number of subjects: 500
Study: 10180718

Group type: EXPERIMENTAL
Intervention: Albuterol inhaled from the piezoelectric device (PED)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Albuterol inhaled from the metered dose inhaler (MDI)
Number of subjects: 0
Study: 8025985

Group type: EXPERIMENTAL
Intervention: Fluosol
Number of subjects: 430
Study: 2689147

Group type: EXPERIMENTAL
Intervention: Super Bond, a 4‐Meta‐PMMA resin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: ABC (Adhesive Bridge Cement)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Microfill pontic, both composite adhesives
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 54
Study: 31722594

Group type: EXPERIMENTAL
Intervention: Liberal RBC transfusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restrictive RBC transfusion
Number of subjects: 0
Study: 30337921

Group type: EXPERIMENTAL
Intervention: HFA‐BDP metered‐dose inhaler (MDI) ETN (n = 11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo MDI ETN (n = 12)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: HFA‐BDP MDI ETN
Number of subjects: 23
Study: 27562424

Group type: EXPERIMENTAL
Intervention: Nocebo group (cognitive manipulation with sham inert cream)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (cognitive manipulation with sham inert cream)
Number of subjects: 30
Study: 25343395

Group type: EXPERIMENTAL
Intervention: 22,600 ppm F‐ varnish applied every six months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo fluoride varnish applied every six months
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 22,600 ppm F‐ varnish
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo fluoride varnish
Number of subjects: 200
Study: 21806617

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing (FMSRP)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Partial-mouth scaling and root planing (PMSRP)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study: 20414547

Group type: EXPERIMENTAL
Intervention: Casein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soy protein
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 18347904

Group type: EXPERIMENTAL
Intervention: Intervention (5 A Day for Better Health)
Number of subjects: 5
Study: 16388329

Group type: EXPERIMENTAL
Intervention: HFE genotyping
Number of subjects: 121

Group type: COMPARATOR
Intervention: Iron test (transferrin saturation measurement)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Genotype group
Number of subjects: 121

Group type: COMPARATOR
Intervention: Phenotype group
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Knowledge assessment
Number of subjects: 121
Study: 12032877

Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Nevirapine (NVP)
Number of subjects: 67
Study: 10831472

Group type: EXPERIMENTAL
Intervention: Supraphysiologic doses of estradiol and progesterone for 8 weeks, followed by withdrawal of both steroids.
Number of subjects: 16
Study: 9467248

Group type: EXPERIMENTAL
Intervention: Intravenous load of hypertonic glucose solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (20 individuals)
Number of subjects: 20
Study: 1410028

Group type: EXPERIMENTAL
Intervention: Osteotomy defect with 30% of cross-sectional area removed
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Osteotomy defect with 37% of cross-sectional area removed
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Osteotomy defect with 50% of cross-sectional area removed
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Beveled or rounded ends of osteotomy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: One-diameter length of bone removed
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Two-diameter length of bone removed
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Three-diameter length of bone removed
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Four-diameter length of bone removed
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group with no alteration to the bone
Number of subjects: 50
Study: 2417434

Group type: EXPERIMENTAL
Intervention: 3% dextran-60 as a plasma substitute
Number of subjects: 60

Group type: COMPARATOR
Intervention: Microaggregate‐poor whole blood
Number of subjects: 60
Study: 30485447

Group type: EXPERIMENTAL
Intervention: Cartilage tympanoplasty (CT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cartilage tympanoplasty combined with eustachian tube balloon dilatation (ETBD+CT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Eustachian tube balloon dilatation (ETBD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (conservative treatment)
Number of subjects: 0
Study: 29550779

Group type: EXPERIMENTAL
Intervention: Body Brain Life-General Practice (BBL-GP)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Lifestyle Modification Programme (LMP)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Email-only programme providing general health information
Number of subjects: 240
Study: 26566669

Group type: EXPERIMENTAL
Intervention: Apixaban 2.5 mg twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Warfarin (adjusted-dose)
Number of subjects: 0
Study: 23446086

Group type: EXPERIMENTAL
Intervention: 1.5% w/w diclofenac sodium in dimethyl sulfoxide
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control solutions containing no diclofenac
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Both groups (active and control)
Number of subjects: 209
Study: 22827167

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 20605255

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg once daily for 6 months
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo once daily for 6 months
Number of subjects: 153
Study: 17645387

Group type: EXPERIMENTAL
Intervention: Familiar live music during chemotherapy (20 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard chemotherapy
Number of subjects: 50
Study: 16127039

Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg administered enterally
Number of subjects: 18

Group type: COMPARATOR
Intervention: Linezolid 600 mg administered intravenously
Number of subjects: 18
Study: 11700782

Group type: EXPERIMENTAL
Intervention: NK1 receptor antagonists
Number of subjects: 245
Study: 9142794

Group type: COMPARATOR
Intervention: MMRV and placebo
Number of subjects: 812

Group type: COMPARATOR
Intervention: MMRV, DTaP, and OPV
Number of subjects: 812

Group type: COMPARATOR
Intervention: MMRV
Number of subjects: 812

Group type: EXPERIMENTAL
Intervention: VARIVAX
Number of subjects: 812
Study: 7974903

Group type: EXPERIMENTAL
Intervention: Combined-modality approach with chemotherapy, radiation therapy, and surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytotoxic agents (bleomycin, methotrexate, cisplatin, 5-FU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 3115419

Group type: EXPERIMENTAL
Intervention: Marathon running (no drugs)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Marathon running (with drugs)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Walking 37 km for four consecutive days (healthy men)
Number of subjects: 47
Study: 2125794

Group type: EXPERIMENTAL
Intervention: BCAA infusion
Number of subjects: 5

Group type: COMPARATOR
Intervention: Normal saline infusion (Control)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Baseline (No infusion)
Number of subjects: 5
Study: 807094

Group type: EXPERIMENTAL
Intervention: Formula diets varying in protein and calorie content (100 or 175 kcal/kg and 1 or 4 g/kg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 100,000 IU water-miscible vitamin A palmitate
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Stabilization period with fluids, antibiotics, and increasing intake of protein and calories to 1 g protein and 100 kcal/kg
Number of subjects: 38
Study: 31843425

Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise interventions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Therapeutic alliance during treatment
Number of subjects: 30
Study: 31034032

Group type: EXPERIMENTAL
Intervention: Clopidogrel plus aspirin (600 mg loading dose on day 1 followed by 75 mg daily for days 2-90)
Number of subjects: 4881

Group type: COMPARATOR
Intervention: Aspirin alone (50 to 325 mg/d)
Number of subjects: 4881
Study: 27013511

Group type: EXPERIMENTAL
Intervention: Varithena 1% (polidocanol endovenous microfoam)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 25577665

Group type: EXPERIMENTAL
Intervention: B. aristata/S. marianum 588/105 mg, 1 tablet during lunch and 1 tablet during dinner for six months
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 23358884

Group type: EXPERIMENTAL
Intervention: Cardiac disease
Number of subjects: 2719

Group type: EXPERIMENTAL
Intervention: Cardiac disease in women
Number of subjects: 2719

Group type: EXPERIMENTAL
Intervention: Cardiac disease in men
Number of subjects: 2719
Study: 22094764

Group type: EXPERIMENTAL
Intervention: Denervation group (surgical denervation by excision of 1 cm of thoracodorsal nerve)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Intact group (thoracodorsal nerve saved intact)
Number of subjects: 28
Study: 19114153

Group type: EXPERIMENTAL
Intervention: Home Visitation Programme (HVP)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 211
Study: 16763533

Group type: EXPERIMENTAL
Intervention: Iloprost (28-day intravenous treatment)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lumbar sympathectomy (LS)
Number of subjects: 200
Study: 15049399

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Loratadine
Number of subjects: 0
Study: 11689736

Group type: EXPERIMENTAL
Intervention: Maximal exercise testing and ABPI measurement in trained cyclists with EILP
Number of subjects: 32

Group type: COMPARATOR
Intervention: Maximal exercise testing and ABPI measurement in untrained individuals
Number of subjects: 32

Group type: COMPARATOR
Intervention: Maximal exercise testing and ABPI measurement in trained cyclists without EILP
Number of subjects: 32
Study: 9135831

Group type: EXPERIMENTAL
Intervention: Branded salbutamol (Ventolin)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Blinded Ventolin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Generic salbutamol
Number of subjects: 29

Group type: COMPARATOR
Intervention: Patient assessment of inhalers
Number of subjects: 29
Study: 8075195

Group type: EXPERIMENTAL
Intervention: Screening detected cancers
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Node positive cases
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Whole series
Number of subjects: 324

Group type: COMPARATOR
Intervention: Clinically detected cancers
Number of subjects: 324
Study: 3296629

Group type: EXPERIMENTAL
Intervention: Oral rehydration
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intravenous rehydration
Number of subjects: 37
Study: 30076156

Group type: EXPERIMENTAL
Intervention: Adalimumab plus methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate monotherapy
Number of subjects: 0
Study: 28768785

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) 1000 mg intravenously
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo (100 ml saline)
Number of subjects: 54
Study: 25883164

Group type: EXPERIMENTAL
Intervention: DialBetics with FoodLog
Number of subjects: 5
Study: 22905971

Group type: EXPERIMENTAL
Intervention: Electronic education programme for twelve weeks
Number of subjects: 48
Study: 21750006

Group type: EXPERIMENTAL
Intervention: Lower levels of physical activity (RR, 0.68 for high versus low)
Number of subjects: 27791

Group type: EXPERIMENTAL
Intervention: Greater body mass index (BMI; RR, 2.14 for ≥35 versus 19.5-24.9 kg/m²)
Number of subjects: 27791

Group type: EXPERIMENTAL
Intervention: Greater height (RR, 2.04 for >66 versus ≤62 inches)
Number of subjects: 27791

Group type: EXPERIMENTAL
Intervention: History of uterine fibroids (RR, 1.72)
Number of subjects: 27791
Study: 19634510

Group type: EXPERIMENTAL
Intervention: Test preparation (clopidogrel 75 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference preparation (clopidogrel 75 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Test preparation (CBS)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference preparation (CBS)
Number of subjects: 48
Study: 16942589

Group type: EXPERIMENTAL
Intervention: Doxazosin GITS 4 mg q.i.d.
Number of subjects: 165

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg q.i.d.
Number of subjects: 165
Study: 15506598

Group type: EXPERIMENTAL
Intervention: Three-piece acrylic IOL
Number of subjects: 493

Group type: COMPARATOR
Intervention: Single-piece acrylic IOL
Number of subjects: 493
Study: 11356438

Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone followed by 400 mg oral misoprostol (home administration)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone followed by 400 mg oral misoprostol (clinic administration)
Number of subjects: 315
Study: 9236560

Group type: EXPERIMENTAL
Intervention: VLED + BT
Number of subjects: 59

Group type: COMPARATOR
Intervention: BT
Number of subjects: 59
Study: 8204244

Group type: EXPERIMENTAL
Intervention: 80 micrograms/kg of preservative‐free epidural morphine with 40 micrograms/kg of butorphanol
Number of subjects: 20

Group type: COMPARATOR
Intervention: 80 micrograms/kg of preservative‐free epidural morphine
Number of subjects: 20
Study: 3074603

Group type: EXPERIMENTAL
Intervention: Flurbiprofen (100 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naproxen sodium (500 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 8
Study: 29982957

Group type: EXPERIMENTAL
Intervention: Vocational Advice Intervention (VAI) delivered by trained physiotherapists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training and mentoring package for Vocational Advisors (VAs)
Number of subjects: 0
Study: 28928110

Group type: EXPERIMENTAL
Intervention: eHealth self‐management intervention (website and mobile phone app)
Number of subjects: 60
Study: 26027866

Group type: EXPERIMENTAL
Intervention: 3D computer-aided planning approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2D planning technique
Number of subjects: 0
Study: 24330729

Group type: EXPERIMENTAL
Intervention: Dissemination strategies including multi-day in-person training workshops, electronic information exchange modalities, and remote technical assistance.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 12
Study: 22174811

Group type: EXPERIMENTAL
Intervention: 200 mg per day of monomeric and oligomeric flavanols (MOF) from grape seeds
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 19224815

Group type: EXPERIMENTAL
Intervention: Hegu group (capsicum plaster at Hegu acupoints)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Sham group (capsicum plaster on shoulders)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (placebo tape at Hegu acupoints and on shoulders)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Hegu group
Number of subjects: 84
Study: 16874418

Group type: EXPERIMENTAL
Intervention: Levocetirizine 5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 12775425

Group type: EXPERIMENTAL
Intervention: Topotecan treatment
Number of subjects: 11
Study: 10851363

Group type: EXPERIMENTAL
Intervention: Conjugated estrogen (Premarin) 1.25 mg/day for 12 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9036414

Group type: EXPERIMENTAL
Intervention: Motivationally supplemented diabetes training
Number of subjects: 43

Group type: COMPARATOR
Intervention: Regular teaching programme
Number of subjects: 43
Study: 1532762

Group type: EXPERIMENTAL
Intervention: Experimental letter designed to increase perceived control
Number of subjects: 71

Group type: COMPARATOR
Intervention: Routine appointment letter (control)
Number of subjects: 71
Study: 6438690

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Hamilton Depression Scale (HDS)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: HDS subscale scores
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Percentage of patients changing categories
Number of subjects: 97
Study: 30278260

Group type: COMPARATOR
Intervention: Didactic learning alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Didactic learning + experiential learning
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Final evaluation after 6 months
Number of subjects: 30
Study: 30420353

Group type: EXPERIMENTAL
Intervention: Care manager (CM) programme, 3 months of contact, n=163
Number of subjects: 342

Group type: COMPARATOR
Intervention: Care as usual (CAU), 3 months of contact, n=179
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: Care manager (CM) programme, 6-month costs
Number of subjects: 342
Study: 26076387

Group type: EXPERIMENTAL
Intervention: I-gel (IG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: LMA-Fastrach (FT)
Number of subjects: 120
Study: 23955928

Group type: EXPERIMENTAL
Intervention: SASA! community-mobilization intervention
Number of subjects: 1206
Study: 21950001

Group type: EXPERIMENTAL
Intervention: Endoscopic thyroidectomy
Number of subjects: 109

Group type: COMPARATOR
Intervention: Open thyroidectomy
Number of subjects: 109
Study: 19671367

Group type: EXPERIMENTAL
Intervention: Corticotrophin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (IVMP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pulsed IVMP
Number of subjects: 0
Study: 17334239

Group type: EXPERIMENTAL
Intervention: Active impedance threshold device
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sham impedance threshold device (control)
Number of subjects: 9